Mutations or deletions in TRPS1 give rise to Tricho-rhino-phalangeal syndrome (TRPS), and a relatively high proportion of patients with TRPS exhibit CHD, ranging from minor to severe anomalies (Verheij et al., 2009; Maas et al., 2015). This evidence concerns the gene TRPS1 and trichorhinophalangeal syndrome.